TY - JOUR
T1 - Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction
AU - Hearon, Christopher M.
AU - Sarma, Satyam
AU - Dias, Katrin A.
AU - Hieda, Michinari
AU - Levine, Benjamin D.
N1 - Funding Information:
This work was supported by the National Institutes of Health (NIH R01 AG 17479, NIH 1F32HL137285-0) and the American Heart Association (AHA-14SFRN20600009-02).
Funding Information:
Funding this work was supported by the national institutes of health (nih r01 ag17479, nih 1F32hl137285-0) and the american heart association (aha-14sFrn20600009-02).
Publisher Copyright:
© 2019 Author(s) (or their employer(s)).
PY - 2019
Y1 - 2019
N2 - Objective The time needed to increase oxygen utilisation to meet metabolic demand (VO2 kinetics) is impaired in heart failure (HF) with reduced ejection fraction and is an independent risk factor for HF mortality. It is not known if VO2 kinetics are slowed in HF with preserved ejection fraction (HFpEF). We tested the hypothesis that VO2 kinetics are slowed during submaximal exercise in HFpEF and that slower VO2 kinetics are related to impaired peripheral oxygen extraction. Methods Eighteen HFpEF patients (68±7 years, 10 women) and 18 healthy controls (69±6 years, 10 women) completed submaximal and peak exercise testing. Cardiac output (acetylene rebreathing, Qc), ventilatory oxygen uptake (VO2, Douglas bags) and arterial-venous O2 difference (a-vO2 difference) derived from Qc and VO2 were assessed during exercise. Breath-by-breath O2 uptake was measured continuously throughout submaximal exercise, and VO2 kinetics was quantified as mean response time (MRT). Results HFpEF patients had markedly slowed VO2 kinetics during submaximal exercise (MRT: control: 40.1±14.2, HFpEF: 65.4±27.7 s; p<0.002), despite no relative impairment in submaximal cardiac output (Qc: control: 8.6±1.7, HFpEF: 9.7±2.2 L/min; p=0.79). When stratified by MRT, HFpEF with an MRT ≥60 s demonstrated elevated Qc, and impaired peripheral oxygen extraction that was apparent during submaximal exercise compared with HFpEF with a MRT <60s (submaximal a-vO2 difference: MRT <60s: 9.7±2.1, MRT ≥60 s: 7.9±1.1 mL/100 mL; p=0.03). Conclusion HFpEF patients have slowed VO2 kinetics that are related to impaired peripheral oxygen utilisation. MRT can identify HFpEF patients with peripheral limitations to submaximal exercise capacity and may be a target for therapeutic intervention.
AB - Objective The time needed to increase oxygen utilisation to meet metabolic demand (VO2 kinetics) is impaired in heart failure (HF) with reduced ejection fraction and is an independent risk factor for HF mortality. It is not known if VO2 kinetics are slowed in HF with preserved ejection fraction (HFpEF). We tested the hypothesis that VO2 kinetics are slowed during submaximal exercise in HFpEF and that slower VO2 kinetics are related to impaired peripheral oxygen extraction. Methods Eighteen HFpEF patients (68±7 years, 10 women) and 18 healthy controls (69±6 years, 10 women) completed submaximal and peak exercise testing. Cardiac output (acetylene rebreathing, Qc), ventilatory oxygen uptake (VO2, Douglas bags) and arterial-venous O2 difference (a-vO2 difference) derived from Qc and VO2 were assessed during exercise. Breath-by-breath O2 uptake was measured continuously throughout submaximal exercise, and VO2 kinetics was quantified as mean response time (MRT). Results HFpEF patients had markedly slowed VO2 kinetics during submaximal exercise (MRT: control: 40.1±14.2, HFpEF: 65.4±27.7 s; p<0.002), despite no relative impairment in submaximal cardiac output (Qc: control: 8.6±1.7, HFpEF: 9.7±2.2 L/min; p=0.79). When stratified by MRT, HFpEF with an MRT ≥60 s demonstrated elevated Qc, and impaired peripheral oxygen extraction that was apparent during submaximal exercise compared with HFpEF with a MRT <60s (submaximal a-vO2 difference: MRT <60s: 9.7±2.1, MRT ≥60 s: 7.9±1.1 mL/100 mL; p=0.03). Conclusion HFpEF patients have slowed VO2 kinetics that are related to impaired peripheral oxygen utilisation. MRT can identify HFpEF patients with peripheral limitations to submaximal exercise capacity and may be a target for therapeutic intervention.
UR - http://www.scopus.com/inward/record.url?scp=85068617252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068617252&partnerID=8YFLogxK
U2 - 10.1136/heartjnl-2019-314797
DO - 10.1136/heartjnl-2019-314797
M3 - Article
C2 - 31208971
AN - SCOPUS:85068617252
SN - 1355-6037
VL - 105
SP - 1552
EP - 1558
JO - Heart
JF - Heart
IS - 20
ER -